Portfolio company
Timberlyne
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops monoclonal antibody therapies for patients with autoimmune disorders and cancers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aeglea BioTherapeutics
This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.
Clim Bio
This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.
FF Pharmaceuticals
This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.
imbiologics
The company develops antibody therapeutics for autoimmune diseases and cancer, providing these biological medicines to pharmaceutical firms and healthcare providers.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
Talix
This drug development company creates monoclonal antibodies for healthcare providers and pharmaceutical partners to treat various forms of cancer through immune-based therapies.
Reverb Therapeutics
This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.
Arxx Therapeutics
This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.
